Exercise training (ET) in adult and elderly patients receiving anti-lymphoma treatments is feasible and may improve the provision of care
Lymphoma treatments can produce adverse effects leading to a reduced quality-of-life (QoL). Besides, in patients ≥65years, it can promote an accelerated geriatric decay. We conducted a prospective study on supervised Exercise-Training (ET), in consecutive, patients aged 18-80years, during anti-lymphoma treatments.16/30 (53%), median-age = 65.5y, participated to the ET sessions, this was the Interventional Group (IG); 14/30 (47%), median-age = 63y, were the Reference Group (RG). Both groups participated to the fitness and the QoL assessments, at baseline (T0), 3-months (T1) and 6-months (T2) after the start of chemotherapy. The adherence to the ET program was 50% (95% CI:36-64%). The IG showed substantial improvements compared to the CG in cardiorespiratory fitness (Cooper test) at both T1 and T2 and in all the functional domain of the QoL questionnaire (QLQ-C30) at T2. This study showed ET, during chemotherapy, is feasible and safe, even in patients ≥65 years. Furthermore, it may improve the provision of care.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:62 |
|---|---|
| Enthalten in: |
Leukemia & lymphoma - 62(2021), 3 vom: 20. März, Seite 560-570 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cox, Maria Christina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Chemotherapy |
|---|
| Anmerkungen: |
Date Completed 27.04.2021 Date Revised 27.04.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/10428194.2020.1842396 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317980262 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317980262 | ||
| 003 | DE-627 | ||
| 005 | 20231225164409.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/10428194.2020.1842396 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1059.xml |
| 035 | |a (DE-627)NLM317980262 | ||
| 035 | |a (NLM)33231126 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cox, Maria Christina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Exercise training (ET) in adult and elderly patients receiving anti-lymphoma treatments is feasible and may improve the provision of care |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.04.2021 | ||
| 500 | |a Date Revised 27.04.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Lymphoma treatments can produce adverse effects leading to a reduced quality-of-life (QoL). Besides, in patients ≥65years, it can promote an accelerated geriatric decay. We conducted a prospective study on supervised Exercise-Training (ET), in consecutive, patients aged 18-80years, during anti-lymphoma treatments.16/30 (53%), median-age = 65.5y, participated to the ET sessions, this was the Interventional Group (IG); 14/30 (47%), median-age = 63y, were the Reference Group (RG). Both groups participated to the fitness and the QoL assessments, at baseline (T0), 3-months (T1) and 6-months (T2) after the start of chemotherapy. The adherence to the ET program was 50% (95% CI:36-64%). The IG showed substantial improvements compared to the CG in cardiorespiratory fitness (Cooper test) at both T1 and T2 and in all the functional domain of the QoL questionnaire (QLQ-C30) at T2. This study showed ET, during chemotherapy, is feasible and safe, even in patients ≥65 years. Furthermore, it may improve the provision of care | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Lymphoma | |
| 650 | 4 | |a chemotherapy | |
| 650 | 4 | |a elderly | |
| 650 | 4 | |a exercise training | |
| 650 | 4 | |a quality-of-life | |
| 650 | 4 | |a survivorship | |
| 700 | 1 | |a Nusca, Sveva Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Di Landro, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Marsilli, Gabriella |e verfasserin |4 aut | |
| 700 | 1 | |a Stella, Giulia |e verfasserin |4 aut | |
| 700 | 1 | |a Sigona, Matilde |e verfasserin |4 aut | |
| 700 | 1 | |a Ponzelli, Federica |e verfasserin |4 aut | |
| 700 | 1 | |a Passerini Desideri, Jasmine |e verfasserin |4 aut | |
| 700 | 1 | |a Di Gregorio, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Santoboni, Flavia |e verfasserin |4 aut | |
| 700 | 1 | |a Vetrano, Mario |e verfasserin |4 aut | |
| 700 | 1 | |a Trischitta, Donatella |e verfasserin |4 aut | |
| 700 | 1 | |a Manno, Renato |e verfasserin |4 aut | |
| 700 | 1 | |a Vulpiani, Maria Chiara |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia & lymphoma |d 1989 |g 62(2021), 3 vom: 20. März, Seite 560-570 |w (DE-627)NLM012624047 |x 1029-2403 |7 nnns |
| 773 | 1 | 8 | |g volume:62 |g year:2021 |g number:3 |g day:20 |g month:03 |g pages:560-570 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/10428194.2020.1842396 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 62 |j 2021 |e 3 |b 20 |c 03 |h 560-570 | ||